Abstract
Virucidal activity of Povidone-Iodine (PVP-I) have not yet been performed specifically on SARS-CoV-2. There have been in vitro studies demonstrating its effectiveness against multiple viruses including related coronaviruses. PVP-I could be effective to reduce viral load from asymptomatic COVID-19 patients and also provide a protective oropharyngeal hygiene measure for the health professionals.
Keywords
License
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Article Type: Short Communication
ELECTRON J GEN MED, Volume 18, Issue 1, February 2021, Article No: em273
https://doi.org/10.29333/ejgm/9616
Publication date: 20 Jan 2021
Article Views: 1599
Article Downloads: 1630
Open Access References How to cite this article